LampropoulouD. I., BalaV. M., ZervaE., PliakouE., FilippouD., GazouliM., & AravantinosG. (2022). The potential role of the combined PARP-1 and VEGF inhibition in severe SARS-CoV-2 (COVID-19) infection. The Journal of Infection in Developing Countries, 16(01), 101-111. https://doi.org/10.3855/jidc.15386